6505--Montelukast NA Chewable Tablets Effective August 09, 2026 to August 08, 2027
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0012
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its NAC Pharmaceuticals office, has issued an award notice for the procurement of Montelukast NA Chewable Tablets. This contract is set to be effective from August 9, 2026, through August 8, 2027, and is identified by procurement number 36E79726R0012. The notice remains active and is accessible via the SAM.gov portal, providing transparency and ongoing information for interested parties.
The primary purpose of this procurement is to secure a reliable supply of Montelukast NA Chewable Tablets, a pharmaceutical product classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and product service code 6505. The scope of the contract encompasses the manufacturing and delivery of these chewable tablets, which are essential for the VA’s ongoing commitment to providing quality healthcare to veterans. The intended outcome is to ensure uninterrupted access to this medication, supporting the VA’s clinical operations and patient care objectives.
Key requirements for this contract include adherence to pharmaceutical manufacturing standards as defined by the NAICS classification, ensuring product quality, safety, and regulatory compliance. The deliverables are expected to be Montelukast NA Chewable Tablets, supplied in quantities and packaging formats specified by the VA, with delivery schedules aligned to the department’s operational needs throughout the contract period.
The contracting entity is NAC Pharmaceuticals, operating under the federal umbrella of the Department of Veterans Affairs. The office is responsible for overseeing the procurement process and ensuring that all contractual obligations are met. Contractors and suppliers interested in this opportunity or seeking further information are encouraged to contact Matthew Poulin, the primary point of contact, via email at [email protected] or by phone at 708-786-5186.
This procurement is classified as an award notice, indicating that the contract has already been awarded and is not open for new bids. There are no set-aside requirements or special considerations specified in the notice. The contract’s parameters, including its classification codes and federal oversight, will remain constant throughout its lifecycle, providing stability and clarity for all stakeholders involved.
For additional details, including any attachments related to the award, interested parties can refer to the official notice on SAM.gov using Opportunity ID ae44ee0b737547e2baa324e06a570f74.
This summary provides a comprehensive overview for contractors evaluating the alignment of their capabilities with the VA’s requirements for Montelukast NA Chewable Tablets, ensuring informed decision-making and engagement with the federal procurement process.